Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
10/2003
10/30/2003WO2003088926A2 Compositions and method of treating alzheimer’s disease
10/30/2003WO2003088924A2 Phosphoinositide 3-kinase mediated inhibition of gpcrs
10/30/2003WO2003088922A2 E7 regulation of p21cip1 through akt
10/30/2003WO2003088917A2 Regulation of tnf-alpha
10/30/2003WO2003088910A2 Methods of assaying for cell cycle modulators
10/30/2003WO2003088904A2 Screening and therapeutic methods for treating circadian rhythm disorders
10/30/2003WO2003088851A1 Tissue penetration device
10/30/2003WO2003088834A1 Method and apparatus for a multi-use body fluid sampling device
10/30/2003WO2003088811A2 Gelsolin as a prognostic marker of artherosclerotic diseases
10/30/2003WO2003088736A1 Fluorescence technique for on-line monitoring of state of hydrogen-producing microorganisms
10/30/2003WO2003073841A3 Transgenic non-human mammals expressing constitutively activated tyrosine kinase receptors
10/30/2003WO2003069301A3 Conductimetric biosensor device, method and system
10/30/2003WO2003061569A3 High-density lipoprotein assay device and method
10/30/2003WO2003058242A3 Internal calibration system for flow-through assays
10/30/2003WO2003057919A3 The use of histamine h4 receptor antagonist for the treatment of inflammatory response
10/30/2003WO2003056293A3 Small molecule microarrays
10/30/2003WO2003055989A3 Cellular compositions and methods of making and using them
10/30/2003WO2003052420A3 Device and bioanalytical method utilizing asymmetric biofunction alized membrane
10/30/2003WO2003048340A3 Crystal structure of mitogen-activated protein kinase-activated protein kinase 2 and binding pockets thereof
10/30/2003WO2003047421A3 Methods and reagents for diagnosis and treatment of diabetes
10/30/2003WO2003046579A3 Cyp46 genotype determination for risk and treatment evaluation of alzheimer's disease
10/30/2003WO2003046004A3 Macroglobulin biopolymer markers indicative of insulin resistance
10/30/2003WO2003044481A3 Optical bio-discs and microfluidic devices for analysis of cells
10/30/2003WO2003038434A3 Serological assay for neospora caninum
10/30/2003WO2003037491A3 Microfluidic micromixer
10/30/2003WO2003036300A3 Diagnosis of cervical cancer
10/30/2003WO2003036263A3 Method and apparatus for parallel dispensing of defined volumes of solid particles
10/30/2003WO2003035693A3 Crystals of cytochrome p450 2c9, structures thereof and their use
10/30/2003WO2003034903A3 Psma antibodies and protein multimers
10/30/2003WO2003034031A3 Highly sensitive methods for protein detection in proteomics
10/30/2003WO2003031568A3 Intracellular signaling molecules
10/30/2003WO2003029482A3 Diagnosing, treating, and preventing cancer using cables
10/30/2003WO2003029480A3 Measurements of multiple molecules using a cryoarray
10/30/2003WO2003029428A3 Use of calmodulin kinase ii inhibitors to treat myocardial dysfunction in structural heart disease
10/30/2003WO2003027681A3 A method of protein analysis
10/30/2003WO2003027143A3 Gene and protein relating to hepatocellular carcinoma
10/30/2003WO2003025199A3 Mid 4460, a human tyrosine phosphatase family member and uses therefor
10/30/2003WO2003023394A8 Kit for screening compounds with low water solubility
10/30/2003WO2003021230A3 High-throughput electrophysiological measurement system
10/30/2003WO2003020415A3 Treatment of substrates using an electrochemical method
10/30/2003WO2003019981A3 Electromagnetic piezoelectric acoustic sensor
10/30/2003WO2003018836A3 Model of autoimmune disease and methods for identifying agents against autoimmune disease
10/30/2003WO2003017042A3 System and method for environmental data acquisition
10/30/2003WO2003016912A3 'lab on chip' from photoresist material for medic al diagnostic applications
10/30/2003WO2003016905A3 Determination of t-cell/mayor histocompatibility complex (mhc) reactivity
10/30/2003WO2003016549A3 Nucleic-acid associated proteins
10/30/2003WO2003014697A3 Amplification of analyte detection with passivated enhancing surfaces having receptors
10/30/2003WO2003011271A3 Methods and compositions for modulating brain damage
10/30/2003WO2003010333A3 Methods for gene disruption and uses thereof
10/30/2003WO2003008635A8 η-SECRETASE IN VITRO SCREENING ASSAY
10/30/2003WO2003006678A3 System and method for storing mass spectrometry data
10/30/2003WO2003006668A3 Haptoglobin Derived Antioxidants
10/30/2003WO2003004698A3 Method for monitoring and modulating protein folding
10/30/2003WO2003000877A3 A soluble complex comprising a retroviral surface glycoprotein
10/30/2003WO2003000717A3 Identification of ses-3 (spr-5) in c. elegans and the uses of the same
10/30/2003WO2002103362A3 Cancer associated protein
10/30/2003WO2002103042A3 Method and nucleic acids for the differentiation of prostate tumors
10/30/2003WO2002102229A3 Diagnosing tumorigenicity and determining resistance to anticancer therapy
10/30/2003WO2002101372A3 System for optimized control of multiple oxidizer feedstreams
10/30/2003WO2002101343A3 Thermal sensor for fluid detection
10/30/2003WO2002100261A3 Point-of-care in-vitro blood analysis system
10/30/2003WO2002099041A3 Ces2s as modifiers of the p53 pathway and methods of use
10/30/2003WO2002098919A3 Method for apo ciii measurement in apob and non apob containing particles
10/30/2003WO2002097444A3 Misfolded protein sensor method
10/30/2003WO2002097390A3 A quantitative hybridization assay for the analysis of nucleic acid
10/30/2003WO2002094876A3 Methods and compositions for treating respiratory mucin production associated disease conditions
10/30/2003WO2002092858A3 Methods of screening for disease
10/30/2003WO2002090511A3 Method for the isolation of stem cells by immuno-labeling with hla/mhc gene product marker
10/30/2003WO2002084294A3 Gastrointestinal glutathione peroxidase in hepatitis c virus infections
10/30/2003WO2002083945A3 Diagnosis and treatment of cancer: i
10/30/2003WO2002074434A3 Surface comprising a pattern of cells and method for production thereof
10/30/2003WO2002073204A3 Cell-based detection and differentiation of disease states
10/30/2003WO2002073172A3 Determination of analytes by means of fluorescence correlation spectroscopy
10/30/2003WO2002072881A3 Method for the amplification and detection of hbv dna using a transcription based amplification
10/30/2003WO2002071060A3 Use of metabolic phenotyping in individualized treatment with amonafide
10/30/2003WO2002070741A3 Methods, systems and computer program products for determining the biological effect and/or activity of drugs, chemical substances and/or pharmaceutical compositions based on their effect on the methylation status of the dna
10/30/2003WO2002070663A3 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
10/30/2003WO2002068697A3 Methods for decreasing non-specific binding of beads in dual bead assays including related optical biodiscs and disc drive systems
10/30/2003WO2002068645A3 Compositions and methods relating to breast specific genes and proteins
10/30/2003WO2002068617A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
10/30/2003WO2002066986A3 Polymers functionalized with fluorescent boronate motifs
10/30/2003WO2002066637A8 Method for collecting and using nuclear mrna
10/30/2003WO2002065118A9 Specimen-linked database
10/30/2003WO2002064784A3 Yeast strain of saccharomyces cerevisiae with functional expression of a glut transporter
10/30/2003WO2002063030A3 Charge tags and separation of nucleic acid molecules
10/30/2003WO2002061430A3 Methods and reagents for treating autoimmune disorders
10/30/2003WO2002061421A3 Screening method for identifying medicaments
10/30/2003WO2002059607A3 Isolation of epidermal stem cells by using the melanoma-associated chondroitin sulfate proteoglycan
10/30/2003WO2002059327A3 Sulfatases and methods of use thereof
10/30/2003WO2002059283A3 Nucleic acid modification enzymes
10/30/2003WO2002056909A3 Method for inducing an immune response to polysaccharide bacterial antigens and to protein structures of virus capsids
10/30/2003WO2002055704A3 Proteins, polynucleotides encoding them and methods of using the same
10/30/2003WO2002054088A3 Contrast enhancement agent for magnetic resonance imaging
10/30/2003WO2002050280A3 Equine ige allotype
10/30/2003WO2002044361A8 Eukaryotic expression libraries based on double lox recombination and methods of use
10/30/2003WO2002039119A3 Method for assaying protein nitrosylation
10/30/2003WO2002034783A3 Transmembrane proteins
10/30/2003WO2002027023A9 Genetic determinants for dermal inflammation and immunity
10/30/2003WO2002018583A9 Modified polypeptides stabilized in a desired conformation and methods for producing same
10/30/2003WO2002017711A9 Therapeutics and diagnostics based on a novel signal transduction system in platelets
1 ... 2474 2475 2476 2477 2478 2479 2480 2481 2482 2483 2484 2485 2486 2487 2488 2489 2490 2491 2492 2493 2494 ... 3937